These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The cellular and molecular-genetic aspects of endothelial dysfunction]. Shliakhto EV; Berkovich OA; Moiseeva OM Vestn Ross Akad Med Nauk; 2004; (10):50-2. PubMed ID: 15575403 [No Abstract] [Full Text] [Related]
3. The endothelium in health and in cardiovascular disease. Garćia-Palmieri MR P R Health Sci J; 1997 Jun; 16(2):136-41. PubMed ID: 9285990 [TBL] [Abstract][Full Text] [Related]
4. Assessment of endothelial function: implications for hypertension and cardiovascular disorders. Butt M; Dwivedi G; Khair O; Lip GY Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):561-3. PubMed ID: 19505269 [No Abstract] [Full Text] [Related]
5. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms. Kapur V; Schwarz ER Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944 [TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and the promise of ACE inhibitors. Rockett JL Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849 [No Abstract] [Full Text] [Related]
7. Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Elliott HL J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S74-7. PubMed ID: 9883752 [TBL] [Abstract][Full Text] [Related]
8. [Endothelial dysfunction]. Nagy J; Csiky B; Kovács T; Wittmann I Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260 [TBL] [Abstract][Full Text] [Related]
9. Diabetes and cardiovascular disease: explaining the relationship. Punthakee Z; Werstuck GH; Gerstein HC Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614 [TBL] [Abstract][Full Text] [Related]
10. [Hypertension 2001]. Kolloch RE Dtsch Med Wochenschr; 2001 Nov; 126(47):1321. PubMed ID: 11719855 [No Abstract] [Full Text] [Related]
11. Functional abnormalities of the vascular endothelium in hypertension and atherosclerosis. Lüscher TF Scand J Clin Lab Invest Suppl; 1990; 199():28-32. PubMed ID: 2191414 [No Abstract] [Full Text] [Related]
12. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Griendling KK; FitzGerald GA Circulation; 2003 Oct; 108(17):2034-40. PubMed ID: 14581381 [No Abstract] [Full Text] [Related]
13. Atherogenesis and cardiovascular disease in women. Rogrigues PO Rev Port Cardiol; 1999; 18 Suppl 3():III9-15. PubMed ID: 10574017 [No Abstract] [Full Text] [Related]
14. [Metabolic angiopathic syndrome--interplay between metabolism and vascular wall]. Nilsson P; Lindholm L; Scherstén B Lakartidningen; 1992 Jul; 89(28-29):2437-9. PubMed ID: 1507962 [No Abstract] [Full Text] [Related]
15. [Endothelial function in high risk cardiovascular patients]. Káli A; Jánosi A Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies in the treatment of endothelial dysfunction: facts and outlook]. Puddu P Ital Heart J Suppl; 2000 Feb; 1(2):212-21. PubMed ID: 10731378 [TBL] [Abstract][Full Text] [Related]
17. [Endothelial function in arterial hypertension and other risk factors for the development of atherosclerosis (a review of the literature--2)]. Soboleva GN; Ivanova OV; Karpov IuA Ter Arkh; 1997; 69(9):80-3. PubMed ID: 9411836 [No Abstract] [Full Text] [Related]